Tuesday 15 April 2014

Global Penile Cancer Clinical Trials Review, H1, Market Hope, Hype And Strategies 2014: Research Background & Research Ideas

Business Research Report On Penile Cancer Global Clinical Trials Review, H1, 2014: Market Research Report

Penile Cancer Global Clinical Trials Review, H1, 2014" provides data on the Penile Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Penile Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Penile Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Browse Full Report With TOC: http://www.marketresearchreports.biz/analysis-details/penile-cancer-global-clinical-trials-review-h1-2014

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

To Get Download Full Report with TOC
: http://www.marketresearchreports.biz/sample/sample/195200

Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Penile Cancer 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Clinical Trials by G7 Countries: Proportion of Penile Cancer to Oncology Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by Phase 15
Clinical Trials by Trial Status 16
Clinical Trials by End Point Status 17
Unaccomplished Trials of Penile Cancer 18
Subjects Recruited Over a Period of Time 19
Clinical Trials by Sponsor Type 20
Prominent Sponsors 21
Top Companies Participating in Penile Cancer Therapeutics Clinical Trials 22
Prominent Drugs 23
Clinical Trial Profiles 24
Clinical Trial Overview of Top Companies 24
Pfizer Inc. 24
Clinical Trial Overview of Pfizer Inc. 24
Onconova Therapeutics, Inc. 25
Clinical Trial Overview of Onconova Therapeutics, Inc. 25
Clinical Trial Overview of Top Institutes / Government 26
European Organization for Research and Treatment of Cancer 26
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 26
National Cancer Institute 27
Clinical Trial Overview of National Cancer Institute 27
Fondazione IRCCS - Istituto Nazionale dei Tumori 28
Clinical Trial Overview of Fondazione IRCCS - Istituto Nazionale dei Tumori 28
University Hospitals Bristol NHS Trust 29
Clinical Trial Overview of University Hospitals Bristol NHS Trust 29
Southwest Oncology Group 30
Clinical Trial Overview of Southwest Oncology Group 30
The University of Texas M. D. Anderson Cancer Center 31
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 31
Hoag Memorial Hospital Presbyterian 32
Clinical Trial Overview of Hoag Memorial Hospital Presbyterian 32
Memorial Sloan Kettering Cancer Center 33
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 33
FUDAN University 34
Clinical Trial Overview of FUDAN University 34
Institute of Cancer Research 35
Clinical Trial Overview of Institute of Cancer Research 35
Five Key Clinical Profiles 36
Appendix 66
Abbreviations 66
Definitions 66
Research Methodology 67
Secondary Research 67
About GlobalData 68
Contact Us 68
Disclaimer 68
Source 69 List of Tables
Penile Cancer Therapeutics, Global, Clinical Trials by Region, 2014* 6
Penile Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Penile Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Penile Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Penile Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Penile Cancer Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Proportion of Penile Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 12
Penile Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Penile Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Penile Cancer Therapeutics, Global, Clinical Trials by Phase, 2014* 15
Penile Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 16
Penile Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 17
Penile Cancer Therapeutics, Global, Suspended Clinical Trials, 2014* 18
Penile Cancer Therapeutics, Global, Terminated Clinical Trials, 2014* 18
Penile Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 19
Penile Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 20

To Read Complete Report with TOC: http://www.marketresearchreports.biz/analysis/195200

Penile Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 21
Penile Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 22
Penile Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 23
Penile Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 24
Penile Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Onconova Therapeutics, Inc., 2014* 25
Penile Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2014* 26
Penile Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 27
Penile Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Fondazione IRCCS - Istituto Nazionale dei Tumori, 2014* 28
Penile Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospitals Bristol NHS Trust, 2014* 29
Penile Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Oncology Group, 2014* 30
Penile Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014* 31
Penile Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Hoag Memorial Hospital Presbyterian, 2014* 32
Penile Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 33
Penile Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2014* 34
Penile Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Institute of Cancer Research, 2014* 35 List of Figures
Penile Cancer Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Penile Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Penile Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Penile Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Proportion of Penile Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 12
Penile Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Penile Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Penile Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2014* 15
Penile Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 16
Penile Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 17
Penile Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 19
Penile Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 20
Penile Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 21
Penile Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 22
Penile Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 23
Methodology 67

About us

MarketResearchReports.biz
is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries. 

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948

Website: http://www.marketresearchreports.biz/
Blog: http://mrrfocuseconomics.blogspot.com/

Iraq Power Market Status, Opportunities, Forecasts Research Report On Outlook to 2030, Update 2014: Information Management

Online Marketing In Iraq Power Market Outlook To 2030, Update 2014 - Market Trends, Regulations And Competitive Landscape: Market Research Report

Summary

This report elaborates Iraqs power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030. Detailed analysis of the Iraq power markets regulatory structure, import and export trends, competitive landscape and power projects at various stages of the supply chain is provided. The report also gives a snapshot of the power sector in Iraq on broad parameters of macroeconomics, supply security, generation infrastructure, transmission infrastructure, degree of competition, regulatory scenario and future potential. Financial performance of the leading power companies is also analyzed in the report.

Browse Full Report With TOC: http://www.marketresearchreports.biz/analysis-details/iraq-power-market-outlook-to-2030-update-2014-market-trends-regulations-and-competitive-landscape

Scope

- Snapshot of the countrys power sector across parameters - macro economics, supply security, generation infrastructure, transmission infrastructure, degree of competition, regulatory scenario and future potential of the power sector.
- Statistics for installed capacity, power generation and consumption from 2000 to 2013, forecast for the next 17 years to 2030.
- Break-up by technology, including thermal, hydro, renewable and nuclear
- Data on leading current and upcoming projects.
- Information on grid interconnectivity, transmission and distribution infrastructure and power exports and imports.
- Policy and regulatory framework governing the market.
- Detailed analysis of top market participant, including market share analysis and SWOT analysis.

Reasons to buy

- Identify opportunities and plan strategies by having a strong understanding of the investment opportunities in the countrys power sector
- Identification of key factors driving investment opportunities in the countrys power sector
- Facilitate decision-making based on strong historic and forecast data
- Develop strategies based on the latest regulatory events
- Position yourself to gain the maximum advantage of the industrys growth potential
- Identify key partners and business development avenues
- Identify key strengths and weaknesses of important market participants
- Respond to your competitors business structure, strategy and prospects

To Get Download Full Report with TOC: http://www.marketresearchreports.biz/sample/sample/195190

Snapshot of Leading Power Generating Companies 45
8.1 Key Company in the Iraq Power Market: Ministry of Electricity of Iraq 45
8.1.1 Company Overview 45
8.1.2 Business Description 45
8.1.3 SWOT Overview 46
9 Appendix 50
9.1 Market Definitions 50
9.1.1 Power 50
9.1.2 Installed Capacity 50
9.1.3 Electricity Generation 50
9.1.4 Electricity Consumption 50
9.1.5 Thermal Power Plant 50
9.1.6 Hydropower Plant 50
9.1.7 Nuclear Power 50
9.1.8 Renewable Energy Resources 51
9.2 Abbreviations 51
9.3 Bibliography 52
9.4 GlobalDatas Methodology 54
9.4.1 Coverage 54
9.4.2 Secondary Research and Analysis 54
9.4.3 Primary Research and Analysis 55
9.5 Disclaimer 56 1.1 List of Tables
Table 1: Power Market, Iraq, Gross Domestic Product ($bn), Population (million) and Annual Power Consumption (TWh), 2000-2018 13
Table 2: Power Market, Iraq, Deal Value ($bn) and Number of Deals, 2004-2012 19
Table 3: Power Market, Iraq, Annual Power Consumption (TWh), 2000-2030 21
Table 4: Power Market, Iraq, Electricity Consumption by Sector (%), 2013 22
Table 5: Power Market, Iraq, Master Plan Financial Requirements ($bn), 2014-2017 24
Table 6: Power Market, Iraq, Cumulative Installed Capacity Breakdown by Fuel Type (%), 2013 27

To Read Complete Report with TOC: http://www.marketresearchreports.biz/analysis/195190

Table 7: Power Market, Iraq, Cumulative Installed Capacity (GW) and Annual Power Generation (TWh), 2000-2030 30
Table 8: Power Market, Iraq, Leading Active Thermal Power Plants, 2013 32
Table 9: Power Market, Iraq, Leading Upcoming Thermal Power Plants, 2014-2030 33
Table 10: Power Market, Iraq, Cumulative Installed Thermal Power Capacity (GW) and Annual Thermal Power Generation (TWh), 2000-2030 35
Table 11: Power Market, Iraq, Cumulative Installed Hydropower Capacity (GW) and Annual Hydropower Generation (TWh), 2000-2030 38
Table 12: Power Market, Iraq, Growth of Transmission System (Ckm), 2000-2020 41
Table 13: Power Market, Iraq, Planned Interconnections by Capacity (MW) and Voltage (kV), 2013 42
Table 14: Power Market, Iraq, Electricity Imports (TWh), 2000-2013 44
Table 15: Power Market, Iraq, Ministry of Electricity of Iraq, SWOT Profile, 2013 46
Table 16: Abbreviations 51 1.2 List of Figures
Figure 1: Power Market, Iraq, Gross Domestic Product ($bn) and Population (million), 2000-2018 12
Figure 2: Power Market, Iraq, Annual Power Consumption (TWh), 2000-2018 12
Figure 3: Power Market, Iraq, Deal Value ($bn) and Number of Deals, 2004-2012 18
Figure 4: Power Market, Iraq, Annual Power Consumption (TWh), 2000-2030 20
Figure 5: Power Market, Iraq, Electricity Consumption by Sector (%), 2013 22
Figure 6: Power Market, Iraq, Cumulative Installed Capacity Breakdown by Fuel Type (%), 2013 27
Figure 7: Power Market, Iraq, Cumulative Installed Capacity (GW) and Annual Power Generation (TWh), 2000-2030 29
Figure 8: Power Market, Iraq, Cumulative Installed Thermal Power Capacity (GW) and Annual Thermal Power Generation (TWh), 2000-2030 34
Figure 9: Power Market, Iraq, Cumulative Installed Hydropower Capacity (GW) and Annual Hydropower Generation (TWh), 2000-2030 37
Figure 10: Power Market, Iraq, Electricity Imports (TWh), 2000-2013 43


About us

MarketResearchReports.biz
is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries. 

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948

Website: http://www.marketresearchreports.biz/
Blog: http://market-recent-report.blogspot.com/

Travel And Tourism In Mexico Market Hope, Hype And Strategies Industry News 2018: Recent Release

Research Background & Research Ideas On Travel And Tourism Market Emerging Opportunities, Trends, Size, Drivers, Strategies, Products And Competitive Landscape Research Report In Mexico To 2018: Information Management

Synopsis

The report provides detailed market analysis, information and insights, including
:

Historic and forecast tourist volumes covering the entire Mexican travel and tourism sector
Detailed analysis of tourist spending patterns in Mexico for various categories in the travel and tourism sector, such as accommodation, sightseeing and entertainment, foodservice, transportation, retail, travel intermediaries and others
Detailed market classification across each category, with analysis using similar metrics
Detailed analysis of the airline, hotel, car rental and travel intermediaries industries

Browse Full Report With TOC: http://www.marketresearchreports.biz/analysis-details/travel-and-tourism-in-mexico-to-2018

Executive summary


The global financial crisis in 2009 had a negative impact on the Mexican travel and tourism sector during the review period (2009–2013). Economic conditions improved and, in 2010, the tourism sector showed signs of recovery, with growth recorded in domestic and international tourist volumes. Timetric expects the growth to continue over the forecast period (2014–2018) as international arrivals rise, driven by increasing tourist volumes from the US and Canada. The Mexican government’s efforts to improve tourism and transportation infrastructure and the tourism board’s efforts to promote Mexico as a leading tourist destination will support the upward trend in tourist volumes.

Scope

To Get Download Full Report with TOC:
http://www.marketresearchreports.biz/sample/sample/195167

This report provides an extensive analysis related to the tourism demands and flows in Mexico
:

It details historical values for the Mexican tourism sector for 2009–2013, along with forecast figures for 2014–2018
It provides a comprehensive analysis of travel and tourism demand factors, with values for both the 2009–2013 review period and the 2014–2018 forecast period
The report provides a detailed analysis and forecast of domestic, inbound and outbound tourist flows in Mexico.
It provides a comprehensive analysis of the trends in the airline, hotel, car rental and travel intermediaries industries, with values for both the 2009–2013 review period and the 2014–2018 forecast period.

Reasons to buy

Take strategic business decisions using historic and forecast market data related to the Mexican travel and tourism sector.
Understand the demand-side dynamics within the Mexican travel and tourism sector, along with key market trends and growth opportunities.

To Read Complete Report with TOC: http://www.marketresearchreports.biz/analysis/195167

Key highlights

The Mexican Riviera, which extends along the Pacific coast from Ensenada in the north to Acapulco in the south, is home to several of the best beaches and resorts in the country. The most popular destinations along the Mexican Riviera are Puerto Vallarta, Cabo San Lucas, the Nayarit Coast and Mazatlán.
The Mexican government plans extensive infrastructure development over the forecast period, investing MXN4.0 trillion (US$315 billion) through the National Infrastructure Program (NIP). It plans to upgrade the country’s infrastructure, including roads, ports, telecommunications, and water and energy facilities.
A rise in manufacturing activities in Mexico will provide job opportunities to residents (leading to an increase in domestic and outbound tourism due to improved income levels) and increase business related tourism to the country. Mexico has an abundance of manufacturing units and is on track to becoming a leading manufacturing hub.
Private companies are expected to invest MXN109.6 billion (US$8.6 billion) in tourism over 2014–2016, with a focus on the construction of new hotels, the renovation of existing ones and improvements to public places. Mexico’s Board of Tourism Businesses expects the investment to create 28,000 direct jobs and 78,000 indirect jobs.
The Mexico Tourism Board (MTB) launched several campaigns in 2013. The ‘Mexico, Live it to Believe It’ campaign was launched in August 2013 and ran until December with an investment of MXN551.8 million (US$43.3 million). In September 2013, the ‘Vallarta – Nayarit. Live it to Believe it!’ campaign was launched with an investment of MXN127.4 million (US$10 million) to promote tourism activity in Riviera Nayarit and Puerto Vallarta.
Domestic low-cost carriers (LCCs) recorded growth in terms of passenger traffic during the review period. According to Official Airline Guide data, in September 2013, LCCs accounted for 59% of the total domestic capacity, up from the 34% share in 2009. The discontinuation of Mexicana’s operations in 2010 and demand for low-cost air travel were responsible for the growth.
Although traditional beach cities such as Cancún, Puerto Vallarta and Acapulco continue to be strong growth centers for the Mexican hospitality industry, other states are beginning to receive substantial private investment and are recording increases in the number of hotels. The five leading states that are rapidly gaining popularity are Baja California, Quintana Roo, Sonora, Guerrero and Nayarit, while the two most important regions of development are Loreto in Baja California and Puerto Peñasco in Sonora.
The majority of car rentals in Mexico are made at airports. Sales from such car rentals accounted for 63.6% of the total market value in 2013, supported by an increase in demand for air travel, air capacity expansions, the launch of new routes and the growth of LCCs.
Increased internet penetration in Mexico has aided the growth of e-commerce. The number of internet users in the country increased by 16% in 2011 to reach 47 million in 2012. According to World Bank data, internet penetration in the country increased from 26.3% in 2009 to 38.4% in 2012. Of the total internet users, 21.6 million, equal to 46%, were listed as e-shoppers in 2012 by the Mexican Internet Association. Plane/bus tickets were the most popular e-commerce purchases.


About us

MarketResearchReports.biz
is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries. 

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948

Website: http://www.marketresearchreports.biz/
Blog: http://market-recent-report.blogspot.com/

Construction Industry In The Netherlands Market Status, Opportunities, Forecasts,Information Management 2014 To 2020: Just Available

Online Business Research On Construction In The Netherlands - Key Trends And Opportunities To 2018: Market Research Report

Synopsis

This report provides detailed market analysis, information and insights into the Dutch construction industry including:

The Dutch construction industry's growth prospects by market, project type and type of construction activity
Analysis of equipment, material and service costs across each project type within the Netherlands
Critical insight into the impact of industry trends and issues, and the risks and opportunities they present to participants in the Dutch construction industry
Analyzing the profiles of the leading operators in the Dutch construction industry
Data highlights of the largest construction projects in the Netherlands

Browse Full Report With TOC: http://www.marketresearchreports.biz/analysis-details/construction-in-the-netherlands-key-trends-and-opportunities-to-2018

Executive summary

The Dutch construction industry recorded a compound annual growth rate (CAGR) of -4.10% during the review period (2009–2013). The country’s economic growth was severely affected by the European financial crisis, resulting in the accumulation of national debt which contributed to 75% of GDP in 2013. In a bid to reduce the debt, the government implemented various austerity measures such as a reduction in public spending. The construction industry’s growth rate is expected to recover over the forecast period, as a result of economic recovery and government efforts to retain the country’s attractiveness as a business center. The industry’s output is expected to increase at a CAGR of 2.02% over the forecast period (2014–2018).

Scope

To Get Download Full Report with TOC: http://www.marketresearchreports.biz/sample/sample/195168

This report provides a comprehensive analysis of the construction industry in the Netherlands. It provides:

Historical (2009–2013) and forecast (2014–2018) valuations of the construction industry in the Netherlands using construction output and value-add methods
Segmentation by sector (commercial, industrial, infrastructure, institutional and residential) and by project type
Breakdown of values within each project type, by type of activity (new construction, repair and maintenance, refurbishment and demolition) and by type of cost (materials, equipment and services)
Analysis of key construction industry issues, including regulation, cost management, funding and pricing
Detailed profiles of the leading construction companies in the Netherlands

Reasons to buy

Identify and evaluate market opportunities using our standardized valuation and forecasting methodologies
Assess market growth potential at a micro-level with over 600 time-series data forecasts
Understand the latest industry and market trends
Formulate and validate business strategies using Timetric's critical and actionable insight
Assess business risks, including cost, regulatory and competitive pressures
Evaluate competitive risk and success factors

To Read Complete Report with TOC: http://www.marketresearchreports.biz/analysis/195168

Key highlights

The Dutch construction industry struggled following the financial crisis in 2008. In 2013, the construction production index, a measure of general construction output, contracted by 4.6%, following a decline of 8.0% in 2012. New building permit approvals also fell following the crisis, declining to its lowest level in nearly two decades in the fourth quarter of 2013. With permits providing an indicator of activity in the coming quarters, the recent slump during 2012 and 2013 does not bode well for output growth in the early part of the forecast period of 2014.
According to CBS, investments by food, drinks and tobacco manufacturers are anticipated to increase by 8.0% in 2014. Dairy product manufacturers in particular plan to invest EUR700.0 million (US$915.0 million) in increasing their processing capacity by 2015. Seven new dairy processing facilities and a number of expansion projects are expected to be complete over the forecast period. According to the Dutch Dairy Association, the increase in investment is due to the growing international demand for products and the planned abolishment of milk quotas in 2015. Increased investment will support the growth of the manufacturing plants category over the forecast period.
The Netherlands has been successful in attracting foreign tourists, due in part to its hosting of numerous cultural and special events such as King’s Day and the International Theatre School Festival. Growth in tourist arrivals supported activity in the construction of tourism infrastructure, particularly hotels. Various hotel projects are scheduled to be completed over the next two years, including two in Amsterdam: the Hyatt Regency hotel, which is scheduled to open in 2015, and Park Inn Hotel by Radisson, expected to open in the fourth quarter of 2014. Growth in the commercial construction market will be driven by the performance of the leisure and hospitality buildings category.
The presence of the world’s largest internet junction and 11 submarine cables provide strong broadband connectivity and make the Netherlands an emerging data center country. Several technology companies are therefore planning to invest in its infrastructure. Microsoft plans to invest EUR2.0 billion (US$2.7 billion) to establish a data center in North Holland, and UK-based BT Group plans to expand the capacity of its data center in the Benelux region, and construct a new facility in Rotterdam. These developments will require an increase in investment in communication infrastructure.
According to the Association of the Dutch Chemical Industry (VNCI), the country’s chemical industry declined in 2013 due to the rising success of the Chinese chemical industry and the growth of specialty chemicals in the Middle East. During the first three quarters of 2013, the chemical industry’s turnover declined by 6.0% and production declined by 5.5%. In order to retain the industry’s competitiveness, the government is reducing regulatory burdens and reinforcing chemical clusters. This move is likely to support the chemical plants category over the forecast period.

About us

MarketResearchReports.biz
is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries. 

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948

Website: http://www.marketresearchreports.biz/
Blog: http://mrrfocuseconomics.blogspot.com/

Monday 14 April 2014

HIV-1 Infection - Pipeline Review, H1 Market Trends, Estimates And Forecasts 2014: Industrial Report

MarketResearchReports.Biz presents this most up-to-date research on "Research Report On HIV-1 Infection - Pipeline Review, H1 Market" 2014

HIV-1 Infection - Pipeline Review, H1 2014, provides an overview of the HIV-1 Infections therapeutic pipeline.


This report provides comprehensive information on the therapeutic development for HIV-1 Infection, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for HIV-1 Infection and special features on late-stage and discontinued projects.

Browse Full Report With TOC: http://www.marketresearchreports.biz/analysis-details/hiv-1-infection-pipeline-review-h1-2014

Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

To Get Download Full Report with TOC: http://www.marketresearchreports.biz/sample/sample/195027

Scope

- The report provides a snapshot of the global therapeutic landscape of HIV-1 Infection
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for HIV-1 Infection and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the HIV-1 Infection products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the HIV-1 Infection pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products

To Read Complete Report with TOC: http://www.marketresearchreports.biz/sample/sample/195027

Reasons to buy

- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies
- Identify and understand important and diverse types of therapeutics under development for HIV-1 Infection
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Devise corrective measures for pipeline projects by understanding HIV-1 Infection pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.


About us

MarketResearchReports.biz
is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries. 

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948

Website: http://www.marketresearchreports.biz/
Blog: http://mrrfocuseconomics.blogspot.com/

Brain Tumor - Pipeline Review, H1 Market Competitive Landscape 2014: Report Overview

MarketResearchReports.Biz presents this most up-to-date research on "Research Report On Brain Tumor - Pipeline Review, H1 Market" 2014

Brain Tumor - Pipeline Review, H1 2014, provides an overview of the Brain Tumors therapeutic pipeline
.

This report provides comprehensive information on the therapeutic development for Brain Tumor, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Brain Tumor and special features on late-stage and discontinued projects.

Browse Full Report With TOC: http://www.marketresearchreports.biz/analysis-details/brain-tumor-pipeline-review-h1-2014

Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

To Get Download Full Report with TOC: http://www.marketresearchreports.biz/sample/sample/195078

Scope

- The report provides a snapshot of the global therapeutic landscape of Brain Tumor
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for Brain Tumor and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the Brain Tumor products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Brain Tumor pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products

To Read Complete Report with TOC: http://www.marketresearchreports.biz/analysis/195078

Reasons to buy

- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies
- Identify and understand important and diverse types of therapeutics under development for Brain Tumor
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Devise corrective measures for pipeline projects by understanding Brain Tumor pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.


About us

MarketResearchReports.biz
is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries. 

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948

Website: http://www.marketresearchreports.biz/
Blog: http://market-recent-report.blogspot.com/

Friday 11 April 2014

Pipeline Review Of Hospital Acquired Pneumonia Drugs Market Status, Opportunities, Market Forecasts 2013 - 2019: Popular Market Report

Pipeline Review Of Hospital Acquired Pneumonia Drugs - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

Hospital acquired pneumonia (HAP) is a pulmonary infectionthat occurs after 48 hours of hospitalization and it was not present at the time of admission. It is the most-common infection and is usually bacterial in origin. The symptoms of pneumonia are cough, fever, nausea, vomiting, shortness of breath, loss of appetite, decreased blood pressure and high heart rate.HAP is the major cause of high morbidity, mortality and cost.Intubation and mechanical ventilation (MV) are risk factors for developingHAP. The development of new diagnostic tools and therapeutic weapons is urgently needed to face the epidemic of multidrug-resistant pathogens.

Browse Full Report With TOC: http://www.marketresearchreports.biz/analysis-details/pipeline-review-of-hospital-acquired-pneumonia-drugs-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019

Hospital Acquired Pneumonia (HAP) - Pipeline Review, provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Hospital Acquired Pneumonia (HAP), with latest updates. Some of the players involved in the therapeutic development for HAP are AstraZeneca, Cubist Pharmaceuticals, Basilea Pharmaceutica, Melinta Therapeutics, Biota Pharmaceuticals, Aridis Pharmaceuticals, Meiji Seika Pharma, Adenium Biotech and Tetraphase Pharmaceuticals.

Scope

•    The report provides a snapshot of the global Hospital Acquired Pneumonia Drugs Market.
•    The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
•    The report reviews key players involved in the development of Hospital Acquired Pneumonia Drugs and enlists all their major and minor projects
•    The report summarizes all the dormant and discontinued pipeline projects
•    Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
•    Coverage of the Hospital Acquired Pneumonia Drugs pipeline on the basis of target, MoA, route of administration and molecule type
•    Latest news and deals relating related to pipeline products

To Get Download Full Report with TOC: http://www.marketresearchreports.biz/sample/toc/194543

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include


•    North America
•    Asia Pacific
•    Europe
•    Rest of the World 

This report provides comprehensive analysis of

•    Market growth drivers
•    Factors limiting market growth
•    Current market trends
•    Market structure
•    Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

To Read Complete Report with TOC: http://www.marketresearchreports.biz/analysis/194543

Reasons to buy

•    Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
•    Develop strategic initiatives by understanding the focus areas of leading companies
•    Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
•    Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


About us

MarketResearchReports.biz
is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries. 

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948

Website: http://www.marketresearchreports.biz/
Blog: http://mrrfocuseconomics.blogspot.com/

Pipeline Review Of Allergic Asthma Drugs Market Trends, Estimates And Forecasts 2013 - 2019: Recent Market Report

Pipeline Review Of Allergic Asthma Drugs - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

Asthma is narrowing of the airway of lungs caused by inflammation in the air passage resulting from both genetic and environmental influences.Allergic asthma is the most common form of asthma.Allergic asthma is triggered by inhaled allergens, such as dust mite allergen, pet dander, pollen, mold, resulting in asthma symptoms.The symptoms of allergic asthma are coughing, wheezing, shortness of breath or rapid breathing and chest tightness. Triggers cause inflammation (swelling and redness) in the airway.

Browse Full Report With TOC: http://www.marketresearchreports.biz/analysis-details/pipeline-review-of-allergic-asthma-drugs-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019

Allergic Asthma - Pipeline Review, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Allergic Asthma, with latest updates. Some of the players involved in the therapeutic development for Allergic asthma are Novartis, Pfizer, F. Hoffmann-La Roche, Panacea Biotec, AstraZeneca, Genentech, Infinity Pharmaceuticals, Portola Pharmaceuticals,ASKA Pharmaceuticaland Trident Pharmaceuticals.

Scope

•    The report provides a snapshot of the global Allergic Asthma Drugs Market.
•    The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
•    The report reviews key players involved in the development of Allergic Asthma Drugs and enlists all their major and minor projects
•    The report summarizes all the dormant and discontinued pipeline projects
•    Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
•    Coverage of the Allergic Asthma Drugs pipeline on the basis of target, MoA, route of administration and molecule type
•    Latest news and deals relating related to pipeline products

To Get Download Full Report with TOC: http://www.marketresearchreports.biz/sample/toc/194541

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

•    North America
•    Asia Pacific
•    Europe
•    Rest of the World 

This report provides comprehensive analysis of

•    Market growth drivers
•    Factors limiting market growth
•    Current market trends
•    Market structure
•    Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

To Read Complete Report with TOC: http://www.marketresearchreports.biz/analysis/194541

Reasons to buy


•    Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
•    Develop strategic initiatives by understanding the focus areas of leading companies
•    Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
•    Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


About us

MarketResearchReports.biz
is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries. 

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948

Website: http://www.marketresearchreports.biz/
Blog: http://market-recent-report.blogspot.com/

Treatment For Syndromes Of Progressive Ataxia And Weakness Disorders Market Growth & Forecast Attractiveness 2013 - 2019: Top Rated Report

Treatment For Syndromes Of Progressive Ataxia And Weakness Disorders Market - Global Industry Analysis, Size, Share, Growth, Trend And Forecast 2013 - 2019

Progressive ataxia and weakness disorders are related to damage, degeneration or loss of neurons of the brain which leads to muscle coordination disability. The market for treatments for syndromes of progressive ataxia and weakness disorders is growing rapidly over the last few years. Some of the major key factors driving the market are novel drug development, rapid technological changes and increased collaborations among industry players towards development of new therapies. Key technological changes involved in market growth are protein misfolding, gene mutation and stem cell therapy. However, recent patent expiries of major drugs are the major restraints for this market.

Browse Full Report With TOC: http://www.marketresearchreports.biz/analysis-details/treatment-for-syndromes-of-progressive-ataxia-and-weakness-disorders-market-global-industry-analysis-size-share-growth-trend-and-forecast-2013-2019

The market is primarily divided into three segments: market by dysfunction or disorders, market by region and the market by technology. Dysfunction or disorders sub-segment include major diseases, such as Friedreich's ataxia, Machado Joseph disease, Hereditary neuropathies, Progressive bulbar palsy and Multiple sclerosis. Regional sub-segment includes market overview, market share and revenue of different region of the world. Technological sub-segment comprises small molecule and monoclonal antibody techniques.

Some of the major players in this market are Abbott, Biogen, Bristol-Myers, Dr. Reddy Laboratories, Eli Lilly, GlaxoSmithKline, Merck, Pfizer and Roche.

To Get Download Full Report with TOC: http://www.marketresearchreports.biz/sample/toc/194540

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

•    North America
•    Asia Pacific
•    Europe
•    Rest of the World 

This report provides comprehensive analysis of

•    Market growth drivers
•    Factors limiting market growth
•    Current market trends
•    Market structure
•    Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

To Read Complete Report with TOC: http://www.marketresearchreports.biz/analysis/194540

Reasons for Buying this Report


•    This report provides pin-point analysis for changing competitive dynamics
•    It provides a forward looking perspective on different factors driving or restraining market growth
•    It provides a technological growth map over time to understand the industry growth rate
•    It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
•    It helps in understanding the key product segments and their future
•    It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
•    It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
•    It provides distinctive graphics and exemplified SWOT analysis of major market segments


About us

MarketResearchReports.biz
is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries. 

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948

Website: http://www.marketresearchreports.biz/
Blog: http://mrrfocuseconomics.blogspot.com/

Treatment For Syndromes Of Dementia And Movement Disorders Market Competitive Landscape 2013 - 2019: New Released Report

Treatment For Syndromes Of Dementia And Movement Disorders Market - Global Industry Analysis, Size, Share, Growth, Trend And Forecast 2013 - 2019

Dementia is a serious brain disorder or damage which leads to memory loss, language and thinking ability. The global market for treatment

Browse Full Report With TOC: http://www.marketresearchreports.biz/analysis-details/treatment-for-syndromes-of-dementia-and-movement-disorders-market-global-industry-analysis-size-share-growth-trend-and-forecast-2013-2019

The global market for treatments for syndromes of Dementia and movement disorders is primarily concentrated on neurodegenerative disorder, which include treatment and therapies for progressive dementia, neurological abnormalities and movement disorders. Some of the key factors driving the growth of this market are increasing prevalence of neurodegenerative diseases, increase in R&D spending, patent expiry of many blockbuster drugs and emergence of new technologies

The market for treatments for syndromes of Dementia and movement disorders comprises two segments: Neurodegenerative disease based drug treatment and Technological treatment. Neurodegenerative diseases include Alzheimer’s disease, Lewy body dementia, Pick’s disease, Huntington’s disease, Parkinson’s disease, etc. Technological area of treatment include immunization strategy, tau tangling inhibitors, biomarkers and monoclonal antibodies.

Some of the key players operating in the market for treatment for syndromes of Dementia and movement disorders are Abbott, Accera, Cadila, Cipla, Eli Lilly, GlaxoSmithKline and Dr. Reddy Laboratories.  

To Get Download Full Report with TOC: http://www.marketresearchreports.biz/sample/toc/194539

s for syndromes of Dementia is witnessing a significant growth in last few years. Rapid technological advancement with increasing number of research in the area of Dementia and other movement disorders are supporting growth to the market. Many pharmaceutical companies are collaborating with research institutes in order to develop new and advanced treatment for syndromes of dementia.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
 
•    North America
•    Asia Pacific
•    Europe
•    Rest of the World 

This report provides comprehensive analysis of

•    Market growth drivers
•    Factors limiting market growth
•    Current market trends
•    Market structure
•    Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

To Read Complete Report with TOC: http://www.marketresearchreports.biz/analysis/194539

Reasons for Buying this Report


•    This report provides pin-point analysis for changing competitive dynamics
•    It provides a forward looking perspective on different factors driving or restraining market growth
•    It provides a technological growth map over time to understand the industry growth rate
•    It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
•    It helps in understanding the key product segments and their future
•    It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
•    It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
•    It provides distinctive graphics and exemplified SWOT analysis of major market segments


About us

MarketResearchReports.biz
is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries. 

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948

Website: http://www.marketresearchreports.biz/
Blog: http://market-recent-report.blogspot.com/

Global Industry Organ And Tissue Transplantation And Alternatives Market Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019: Industrial Report

Organ And Tissue Transplantation And Alternatives Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

Organ transplantation is the process of transplant of an organ from one body to another or from donor site to another recipient site for the purpose of replacing the damaged or absent organ.  Organ transplantation is the last therapeutic option for the treatment in the final stage of organ failure. Organs that can be transplanted are heart, kidney, liver, lungs, pancreas, intestine, and thymus. Tissues that can be transplanted include bones, tendons, cornea, skin, heart valves, nerves and veins.

Browse Full Report With TOC: http://www.marketresearchreports.biz/analysis-details/organ-and-tissue-transplantation-and-alternatives-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019

Organ and tissue transplantation is a rapidly growing field due to increasing prevalence of organ and tissue failure diseases. Better harvesting and procurement techniques, vastly improved immunosuppression regimens, advance tissue matching and effective anti-infective regimens are also supporting the growth of organ and tissue transplantation market. Lack of artificial organs and organ donors pose a major challenge for the industry. However, increasing investments on research and development are expected to bring better opportunities for the market.

The market of organ and tissue replacement can be divided in to various parts, such as tissue typing technology, solid organ procurement and preservation, tissue products, immunosuppressant, post translational monitoring of tissue and organ and alternative devices and technologies. Tissue typing technologies include panel typing reactive and sequence typing. Solid organ procurement and preservation comprises organ procurement in different regions of the world, such as the U.S., EU, Japan and China. Tissue products segments include various transplant products, such as heart valve, stem cells and bone matrix products. Alternative devices and technologies include devices for corneal, intestinal and pancreas transplantation.

Some of the major players in the market of organ and tissue transplantation are Abbott, Arthrex, Bristol-Myers, Biomet, Celera, Centacor and Novartis.

To Get Download Full Report with TOC: http://www.marketresearchreports.biz/sample/toc/194538

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

•    North America
•    Asia Pacific
•    Europe
•    Rest of the World 

This report provides comprehensive analysis of
•    Market growth drivers
•    Factors limiting market growth
•    Current market trends
•    Market structure
•    Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

To Read Complete Report with TOC: http://www.marketresearchreports.biz/analysis/194538

Reasons for Buying this Report
•    This report provides pin-point analysis for changing competitive dynamics
•    It provides a forward looking perspective on different factors driving or restraining market growth
•    It provides a technological growth map over time to understand the industry growth rate
•    It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
•    It helps in understanding the key product segments and their future
•    It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
•    It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
•    It provides distinctive graphics and exemplified SWOT analysis of major market segments


About us

MarketResearchReports.biz
is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries. 

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
Website:
http://www.marketresearchreports.biz/
Blog:
http://mrrfocuseconomics.blogspot.com/

Thursday 10 April 2014

Global Small And Medium Scale LNG Industry Outlook To 2020: Global Industry Analysis, Size, Share, Growth, Trends and Forecast

MarketResearchReports.Biz presents this most up-to-date research on "Research Report On Global Small And Medium Scale LNG Industry Outlook To 2020 - Asia Pacific And European Markets To Drive Industry Growth In Short Term Future: Research Background & Research Ideas

Global Small and Medium Scale LNG Industry Outlook to 2020- Asia Pacific and European Markets to Drive Industry Growth in Short Term Future from LNGANALYSIS is a unique publication on global small and medium scale LNG industry. The report provides information on the industry outlook to 2020. It also analyzes the leading trends shaping the future of small LNG markets in current uncertain times. A total of 35 potential small/medium scale LNG markets with their infrastructure and key market details are provided.

Browse Full Report With TOC: http://www.marketresearchreports.biz/analysis-details/global-small-and-medium-scale-lng-industry-outlook-to-2020-asia-pacific-and-european-markets-to-drive-industry-growth-in-short-term-future

Analysis of leading nine technology providers along with their operational and planned LNG projects is provided. Further, location, start up, company, capacities and technology information for around 300 operational and planned projects are provided in detail. The report also analyzes the capacity changes over the historic period and forecasts to 2020. In addition, all major industry developments and news landscape are provided in the report.

TABLE OF CONTENTS

1 TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures

2 GLOBAL SMALL/ MEDIUM SCALE LNG INDUSTRY OVERVIEW
2.1 Global Small Scale LNG Capacity forecast to 2020
2.1.1 Small Scale LNG Industry - Key Benefits
2.1.2 Small Scale LNG Industry - Key Challenges
2.1.3 Industry Scope
2.1.4 Applications of Small LNG
2.2 Supply Chain of Mini Scale LNG Projects
2.3 Small Scale LNG vs. Large (Base Load) LNG

To Get Download Full Report with TOC: http://www.marketresearchreports.biz/sample/sample/185715

3 POTENTIAL INVESTMENT OPPORTUNITIES FOR SMALL LNG TERMINALS
3.1 Russian Federation looks to strengthen its position in Baltic and Black Seas
3.2 South East Asia - Gas Demand in Power Generation and Marine sector drive Small LNG Industry growth
3.2.1 Indonesia
3.2.2 Singapore
3.2.3 Southern Philippines and Northern Vietnam
3.2.4 Malaysia
3.3 Baltic Sea - LNG Consumption as Marine Fuel
3.4 Trinidad and Tobago, Bolivia, Colombia and Dominican Republic plan New Terminals
3.5 Small European Gas markets - Finland, Poland, Latvia, Lithuania and Scotland
3.6 Emerging Gas Hubs - Netherlands and Singapore
3.7 Large Geographic Areas - China, Australia, India, Russia and Indonesia

4 ANALYSIS OF SMALL AND MID SCALE LIQUEFACTION AND REGASIFICATION TECHNOLOGIES
4.1 Analysis of Available Technologies
4.2 Linde Engineering - Technologies and Processes
4.2.1 Operational and Planned Small LNG Projects of Linde Engineering
4.3 APCI LNG - Technologies and Processes
4.3.1 Operational and Planned Small LNG Projects of APCI Technologies
4.4 Black and Veatch - Technologies and Processes
4.4.1 Operational and Planned Small LNG Projects of B&V
4.5 Kryopak - Technologies and Processes

To Read Complete Report with TOC: http://www.marketresearchreports.biz/analysis/185715

5 PLANNED SMALL AND MID SCALE LNG TERMINALS

5.1 Small and Mid Scale Terminals Scheduled for operation in 2013
5.2 Small and Mid Scale Terminals Scheduled for operation in 2014
5.3 Small and Mid Scale Terminals Scheduled for operation in 2015
5.4 Small and Mid Scale Terminals Scheduled for operation in 2016 - 2018


About us

MarketResearchReports.biz
is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries. 

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948

Website: http://www.marketresearchreports.biz/
Blog: http://market-recent-report.blogspot.com/

Arromax Pharmatech, Co. Ltd. - Product Pipeline Review Market News 2014: Worldwide Business Survey

Market survey On Arromax Pharmatech, Co. Ltd. - Product Pipeline Review - 2014: Global Industry Analysis, Size, Share, Growth, Trends and Forecast

Global Markets Direct’s, ‘Arromax Pharmatech, Co. Ltd. - Product Pipeline Review - 2014’, provides an overview of the Arromax Pharmatech, Co. Ltd.’s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Arromax Pharmatech, Co. Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Browse Full Report With TOC: http://www.marketresearchreports.biz/analysis-details/arromax-pharmatech-co-ltd-product-pipeline-review-2014

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

To Get Download Full Report with TOC: http://www.marketresearchreports.biz/sample/sample/193831

Scope

•    The report provides brief overview of Arromax Pharmatech, Co. Ltd. including business description, key information and facts, and its locations and subsidiaries
•    The report reviews current pipeline of Arromax Pharmatech, Co. Ltd.’s human therapeutic division and enlists all their major and minor projects
•    The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
•    Special feature on out-licensed and partnered product portfolio
•    The report summarizes all the dormant and discontinued pipeline projects
•    Latest company statement
•    Latest news and deals relating to the Arromax Pharmatech, Co. Ltd.’s pipeline products

To Read Complete Report with TOC: http://www.marketresearchreports.biz/analysis/193831

Reasons to buy


•    Evaluate Arromax Pharmatech, Co. Ltd.’s strategic position with total access to detailed information on its product pipeline
•    Assess the growth potential of Arromax Pharmatech, Co. Ltd. in its therapy areas of focus
•    Identify new drug targets and therapeutic classes in the Arromax Pharmatech, Co. Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
•    Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
•    Develop strategic initiatives by understanding the focus areas of Arromax Pharmatech, Co. Ltd. and exploit collaboration and partnership opportunities
•    Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
•    Plan mergers and acquisitions effectively by identifying the most promising pipeline of Arromax Pharmatech, Co. Ltd.
•    Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
•    Explore the dormant and discontinued projects of Arromax Pharmatech, Co. Ltd. and identify potential opportunities in those areas
•    Avoid Intellectual Property Rights related issues


About us

MarketResearchReports.biz
is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries. 

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948

Website: http://www.marketresearchreports.biz/
Blog: http://mrrfocuseconomics.blogspot.com/

Psoriasis - Pipeline Review, H1 Market Trends & Growth Research Report 2014: Report Overview

Market Survey On Psoriasis - Pipeline Review, H1 2014: Global Industry Emerging Opportunities, Trends, Size, Drivers, Strategies, Products And Competitive Landscape

‘Psoriasis - Pipeline Review, H1 2014’, provides an overview of the Psoriasis’s therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Psoriasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Psoriasis and special features on late-stage and discontinued projects.

Browse Full Report with TOC: http://www.marketresearchreports.biz/analysis-details/psoriasis-pipeline-review-h1-2014

Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updating following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.


Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/sample/193853

Scope

•    The report provides a snapshot of the global therapeutic landscape of Psoriasis
•    The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
•    The report reviews key players involved in the therapeutics development for Psoriasis and enlists all their major and minor projects
•    The report summarizes all the dormant and discontinued pipeline projects
•    A review of the Psoriasis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
•    Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
•    A detailed assessment of monotherapy and combination therapy pipeline projects
•    Coverage of the Psoriasis pipeline on the basis of target, MoA, route of administration and molecule type
•    Latest news and deals relating related to pipeline products
Reasons to buy
•    Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
•    Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
•    Develop strategic initiatives by understanding the focus areas of leading companies
•    Identify and understand important and diverse types of therapeutics under development for Psoriasis
•    Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Visit Analysis Report: http://www.marketresearchreports.biz/analysis/193853

Table of Contents

Introduction


Psoriasis Overview
Therapeutics Development
Psoriasis - Therapeutics under Development by Companies
Psoriasis - Therapeutics under Investigation by Universities/Institutes
Psoriasis - Pipeline Products Glance
Psoriasis - Products under Development by Companies
Psoriasis - Products under Investigation by Universities/Institutes
Psoriasis - Companies Involved in Therapeutics Development
Psoriasis - Therapeutics Assessment
Drug Profiles
Psoriasis - Recent Pipeline Updates
Psoriasis - Dormant Projects
Psoriasis - Discontinued Products
Psoriasis - Product Development Milestones

Appendix

Number of Products under Development for Psoriasis, H1 2014
Number of Products under Development for Psoriasis - Comparative Analysis, H1 2014
Number of Products under Development by Companies, H1 2014
Number of Products under Development by Companies, H1 2014 (Contd..1)
Number of Products under Development by Companies, H1 2014 (Contd..2)
Number of Products under Development by Companies, H1 2014 (Contd..3)
Number of Products under Development by Companies, H1 2014 (Contd..4)
Number of Products under Development by Companies, H1 2014 (Contd..5)
Number of Products under Development by Companies, H1 2014 (Contd..6)
Number of Products under Development by Companies, H1 2014 (Contd..7)

Psoriasis - Pipeline by Cold Genesys, Inc., H1 2014
Psoriasis - Pipeline by Cancer Prevention Pharmaceuticals, Inc., H1 2014
Psoriasis - Pipeline by Zensun (Shanghai) Sci & Tech Co., Ltd., H1 2014
Psoriasis - Pipeline by PsiOxus Therapeutics, Ltd., H1 2014
Psoriasis - Pipeline by Hanmi Pharmaceuticals, Co. Ltd., H1 2014
Psoriasis - Pipeline by CureFAKtor Pharmaceuticals. LLC, H1 2014
Psoriasis - Pipeline by Kancera AB, H1 2014
Psoriasis - Pipeline by Jasco Pharmaceuticals, LLC., H1 2014


About us

MarketResearchReports.biz
is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries. 

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948

Website: http://www.marketresearchreports.biz/
Blog: http://market-recent-report.blogspot.com/

Wednesday 9 April 2014

Smart Windows Markets Hope, Hype And Strategies 2014-2021: New Released Report

Global Industry Smart Windows Markets Analysis, Size, Share, Growth, Trends and Forecast Research News 2014-2021: Research and Markets

smart windows for five years and has produced detailed studies of this market and related businesses including the smart windows materials markets and smart auto glass. Our understanding of new high-tech glass markets has been further enhanced by our studies of BIPV glass, self-healing and self-cleaning glass and various segments of the display glass sector.

Browse Full Report With TOC: http://www.marketresearchreports.biz/analysis-details/smart-windows-markets-2014-2021

As part of our ongoing coverage of the smart windows sector, NanoMarkets has compiled numerous market forecasts in this space for the buildings/construction and aerospace sectors, with breakouts by type of smart windows technology and geographical region served.

In this report, we present a compendium of our eight-year projections in both volume (square meters) and value ($ millions) terms.  We have updated our forecasts from 2013, both adjusting our numbers for current conditions in the smart windows business and bringing our forecasts up to date with numbers for 2021.

As part of the overall analysis, this report also examines the cost and technical challenges that will have to be overcome for the smart windows markets to make new products a success.  In addition, this report also develops a roadmap for the next-generation smart windows technologies, especially with regard to more effective self-dimming and self-cleaning glass, as well as hybrid smart windows/BIPV glass.

believes that this report will provide guidance to all those interested in the business prospects for smart windows and the technologies that make them possible. NanoMarkets believes that those who will benefit from purchasing this study will include marketing and business development executives in the glazing, coatings, construction, automotive and aerospace industries.

To Get Download Full Report with TOC: http://www.marketresearchreports.biz/sample/sample/193705 

TABLE OF CONTENTS


EXECUTIVE SUMMARY

E.1 Prospects for Passive Tinting Materials:  Are There Any?
E.1.1 Passive Retrofit Window Films:  Still the One to Beat
E.1.2 Passive Thermochromic Windows
E.1.3 Passive Photochromic Windows
E.2 Active Smart Windows:  The Future?
E.2.1 Electrochromic Active Smart Windows
E.2.2 SPD Active Smart Windows
E.2.3 PDLC Privacy Windows
E.3 Thoughts on the Opportunities with Self-Cleaning and Self-Healing Windows
E.4 Opportunities for Construction and Architectural Firms
E.5 Opportunities for Transportation Equipment Manufacturers
E.5.1 Automotive Industry:  Style and Substance
E.5.2 Aerospace Industry:  A Place to Start With New Windows Ideas
E.6 Opportunities for Materials Firms
E.6.1 Glass and Windows Firms
E.6.2 Coatings and Films Companies
E.7 Six Firms to Watch in the Smart Windows Space
E.8 Regions and Countries to Watch
E.8.1 U.S. – Construction Boom, Bust or What?
E.8.2 Europe-the Environmentalism on the Wane
E.8.3 China and Non-Japan Asia—Growth
with Caution
E.8.4 Japan:  Construction and Alternative Energy Doing Well
E.9 Summary of the Eight-Year Forecasts for the Smart Windows Market

To Read Complete Report with TOC: http://www.marketresearchreports.biz/analysis/193705 

CHAPTER ONE: INTRODUCTION

1.1 Background to this Report
1.2 Objectives and Scope of This Report
1.3 Methodology of this Report
1.4 Plan of this Report

CHAPTER TWO: PASSIVE SMART WINDOW PRODUCTS AND TECHNOLOGIES

2.1 Smart Windows:  Passive versus Active

2.2 Passive Retrofit Window Films
2.3 Key Technology Developments and Suppliers
2.3.1 Thermochromics
2.3.2 Photochromics
2.4 Customers Base for Passive Smart Windows in the Construction Industry
2.5 Customers Base for Passive Smart Windows in Automotive and Aerospace


About us

MarketResearchReports.biz
is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries. 

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948

Website: http://www.marketresearchreports.biz/
Blog: http://mrrfocuseconomics.blogspot.com/